Cargando…
1276. Evaluation of CD377, a Novel Antiviral Fc-Conjugate (AVC), In Vitro Activity and In Vivo Efficacy in Immune-Competent and -Deficient (SCID) Lethal Mouse Models
BACKGROUND: Cidara’s AVCs are novel, potent, antiviral agents conjugated with the Fc domain of human IgG1. CD377 is an AVC development candidate being evaluated for prevention and treatment of seasonal and pandemic influenza, including in immune-deficient populations unable to benefit from vaccinati...
Autores principales: | Levin, James, Amundson, Karin, Borchardt, Allen, Lam, Thanh, Brady, Tom, Abelovski, Elizabeth, Döhrmann, Simon, Cole, Jason, Ong, Voon, Tari, Les |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776346/ http://dx.doi.org/10.1093/ofid/ofaa439.1460 |
Ejemplares similares
-
1283. New Generation Antiviral Conjugate (AVC): Stable, Safe, and Single
por: Ong, Voon, et al.
Publicado: (2020) -
159. efficacy of CD377, a Novel Antiviral Fc-conjugate, Against Seasonal Influenza in Lethal Mouse Infection Models
por: Levin, James, et al.
Publicado: (2020) -
689. Therapeutic Efficacy of CB-012, a Novel Cloudbreak Antiviral Fc-Conjugate (AVC) in Lethal Mouse Models of Influenza A (H1N1) and Influenza B (Victoria)
por: Levin, James, et al.
Publicado: (2019) -
162. CD377, a Novel Antiviral Fc-conjugate, Demonstrates Potent Viral Burden Reduction Against Influenza a (H1N1) in Mouse and Ferret Models
por: Döhrmann, Simon, et al.
Publicado: (2020) -
2062. In Vivo Efficacy of CD388, a Novel Drug Fc-Conjugate (DFC), Against Seasonal Subtypes of Influenza in Prophylaxis in Immune Competent Mice, and in a Severe Immunodeficient (SCID) Mouse Model
por: Levin, James, et al.
Publicado: (2023)